Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Apr 15, 2026

Autoliv (ALV) Q1 2026 Earnings Preview: What Investors Need to Watch

Key Takeaways

  • Analysts expect Q1 2026 EPS of around $1.78-$1.93, down from $2.15 in Q1 2025 amid seasonally weaker margins.
  • Revenue consensus at approximately $2.61 billion, slightly below Q1 2025's $2.58 billion.
  • Company guided for Q1 adjusted operating margin considerably weaker than last year's 9.9%.
  • Full-year 2026 outlook steady: ~0% organic sales growth, 10.5-11.0% adjusted operating margin.
  • Autoliv beat EPS estimates in the prior four quarters, including Q4 2025's $3.19 vs. $2.85 expected.
  • Investors watching passive safety demand and cost controls in a softening auto production environment.

Earnings Context and Why It Matters

As a leading supplier of automotive safety systems like airbags and seatbelts, Autoliv (ALV) has its Q1 2026 earnings report coming up on April 17. This covers the January-March period, which is typically the weakest quarter due to lower vehicle production after the year-end rush. With global light vehicle production stabilizing after recent declines, I'm focused on how resilient Autoliv's passive safety segment—its biggest sales driver—will prove to be. The recent beats, such as Q4 2025's record sales and cash flow, lifted shares, but softening OEM production and inventory adjustments present clear risks. Strong execution here could reinforce the 2026 guidance and influence valuation in this competitive auto supplier space.

Earnings Expectations

Consensus estimates for Autoliv's Financial Report January-March 2026 point to EPS of $1.78 according to the company's consensus from 18 analysts as of April 14, with a range of $1.65-$1.97. Revenue is projected at around $2.61 billion per MarketBeat, suggesting flat to modest growth compared to Q1 2025's $2.58 billion. Adjusted operating income is anticipated at $209 million, or an 8.0% margin, accounting for seasonal pressures.

In Q4 2025, Autoliv (ALV) delivered net sales of $2.817 billion, up 7.7% year-over-year, adjusted operating income of $337 million, and adjusted diluted EPS of $3.19—beating expectations of $2.85 EPS and $2.77 billion in sales. The company has guided for Q1 margins below last year's 9.9%, with sequential improvement expected afterward toward the full-year 10.5-11.0% adjusted operating margin. Key metrics I'll be tracking include organic sales growth versus light vehicle production, adjusted EBIT margin, and operating cash flow trends. Historically, Autoliv shares have risen about 2-5% after a beat, though misses can hit harder in down markets. I also checked this using Tickeron’s AI Screener to gauge how the stock stacks up against industry peers on these patterns.

Market Reaction and Investor Sentiment

Sentiment heading into Q1 earnings is cautiously optimistic, supported by four straight EPS beats and the reaffirmed FY 2025 record cash flow target of $1.2 billion. Shares are trading at about 11.5x trailing EPS, near sector lows amid auto sector challenges. Implied volatility points to a potential 5-7% move post-earnings. On the risk side, weaker-than-expected light vehicle production or margin erosion from raw materials could weigh in; upside might come from cost savings or wins in passive safety.

Forward Outlook and Key Factors to Monitor

Autoliv's FY 2026 guidance sets the baseline: organic sales growth near 0%, offset by about 1% positive FX impact, aiming for 10.5-11.0% adjusted operating margin and roughly $1.2 billion in operating cash flow—flat to the prior year.

After Q1, one thing that stands out is the sequential margin recovery expected in the first half, as guided. Demand trends in passive safety, which accounts for about 75% of sales through airbags and seatbelts, versus active safety, will help gauge resilience amid EV shifts and inventory normalization.

Cost trends are critical: ongoing reductions helped deliver Q4's 12.0% margin despite slowing sales growth. Raw material costs like steel and chemicals, along with supply chain dynamics, could either pressure or support those targets.

Upcoming catalysts include Q2 earnings in July 2026, the AGM on May 7, and OEM awards for next-generation safety tech. Broader light vehicle production forecasts from S&P Global and IHS Markit will provide context. From what I see, balanced execution could keep supporting shareholder returns through dividends and buybacks.

Discovering Opportunities with Tickeron’s AI Screener

In my own research process, I rely on Tickeron’s AI Screener, an AI-powered tool for discovering stocks and ETFs. It lets me filter thousands of assets using customizable criteria like technical patterns, fundamentals, trends, volatility, and AI-driven signals—such as industry, market cap, indicators, price patterns, and performance metrics. This helps pinpoint trade ideas, trending stocks, breakouts, and opportunities far more efficiently than manual scans. It's become a key part of how I enhance my analysis, and I find it particularly useful for stocks like ALV in volatile sectors.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: ALV

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


ALV in downward trend: 10-day moving average moved below 50-day moving average on September 16, 2026

The 10-day moving average for ALV crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALV as a result. In 61 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.

The Moving Average Convergence Divergence Histogram (MACD) for ALV turned negative on September 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 28 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.

ALV moved below its 50-day moving average on September 14, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

The Aroon Indicator for ALV entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALV advanced for three days, in 208 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

ALV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.353) is normal, around the industry mean (6.969). P/E Ratio (13.447) is within average values for comparable stocks, (71.549). Projected Growth (PEG Ratio) (0.849) is also within normal values, averaging (1.471). ALV has a moderately high Dividend Yield (0.031) as compared to the industry average of (0.011). P/S Ratio (0.789) is also within normal values, averaging (49.084).

The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 55 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. ALV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

Notable companies

The most notable companies in this group are AutoZone (NYSE:AZO), Advance Auto Parts (NYSE:AAP), Goodyear Tire & Rubber Company (The) (NASDAQ:GT).

Industry description

OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.

Market Cap

The average market capitalization across the Auto Parts: OEM Industry is 4.89B. The market cap for tickers in the group ranges from 1.93K to 69.98B. ORLY holds the highest valuation in this group at 69.98B. The lowest valued company is CREVF at 1.93K.

High and low price notable news

The average weekly price growth across all stocks in the Auto Parts: OEM Industry was 0%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -9%. SES experienced the highest price growth at 57%, while ECX experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Auto Parts: OEM Industry was -10%. For the same stocks of the Industry, the average monthly volume growth was 63% and the average quarterly volume growth was -15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 59
Price Growth Rating: 61
SMR Rating: 78
Profit Risk Rating: 88
Seasonality Score: 29 (-100 ... +100)
View a ticker or compare two or three
ALV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of automotive safety systems for automobile manufacturers

Industry AutoPartsOEM

Industry
Auto Parts OEM
Address
Klarabergsviadukten 70
Phone
+46 858720600
Employees
64300
Web
https://www.autoliv.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.